<SEC-DOCUMENT>0001171843-16-010498.txt : 20160606
<SEC-HEADER>0001171843-16-010498.hdr.sgml : 20160606
<ACCEPTANCE-DATETIME>20160606160514
ACCESSION NUMBER:		0001171843-16-010498
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20160601
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
FILED AS OF DATE:		20160606
DATE AS OF CHANGE:		20160606

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anika Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043145961
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		161698617

	BUSINESS ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730
		BUSINESS PHONE:		(781) 457-9000

	MAIL ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA THERAPEUTICS INC
		DATE OF NAME CHANGE:	19970114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k_060616.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt -22.5pt 1pt 0in"><DIV STYLE="font-size: 0.75pt; border-top: Black 0.75pt solid; border-bottom: Black 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">UNITED STATES</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">Washington, D.C. 20549</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">FORM 8-K</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">CURRENT REPORT</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">PURSUANT TO SECTION 13 OR 15(d)</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">OF THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">Date of Report (Date of earliest event reported): June 1, 2016</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">Anika Therapeutics, Inc.</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>(Exact name of registrant as specified in its charter)</I></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">____________________</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: middle">
    <TD STYLE="text-align: center; width: 33%">Massachusetts</td>
    <TD STYLE="text-align: center; width: 34%">000-21326</td>
    <TD STYLE="text-align: center; width: 33%">04-314-5961</td></tr>
<tr style="vertical-align: middle">
    <td style="font-style: italic; text-align: center">(State or other jurisdiction of</td>
    <TD STYLE="font-style: italic; text-align: center">Commission file number</td>
    <TD STYLE="font-style: italic; text-align: center">(I.R.S. Employer</td></tr>
<tr>
    <td style="font-style: italic; vertical-align: middle; text-align: center">incorporation or organization)</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD STYLE="font-style: italic; vertical-align: middle; text-align: center">Identification No.)</td></tr>
</table>


<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">32 Wiggins Avenue, Bedford, MA 01730</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>(Address of principal executive offices) (Zip code)</I></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>Registrant&rsquo;s telephone number, including area code: </I>781-457-9000</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>(Former name or former address, if changed since last report)</I></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">____________________</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">[_]<FONT STYLE="font-size: 10pt"> Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</FONT></P>

<P STYLE="font-size: 10pt; text-indent: 4.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">[_]<FONT STYLE="font-size: 10pt"> Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">[_]<FONT STYLE="font-size: 10pt"> Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">[_]<FONT STYLE="font-size: 10pt"> Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt -22.5pt 1pt 0in"><DIV STYLE="font-size: 0.75pt; border-top: Black 0.75pt solid; border-bottom: Black 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>Section 5&mdash;Corporate Governance and Management</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">Item 5.07. Submission of Matters to a Vote of Security Holders.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">The Company held its Annual Meeting of Stockholders on June 1, 2016.
Proxies were solicited pursuant to the Company&rsquo;s proxy statement filed on April 20, 2016 with the Securities and Exchange
Commission under Section 14(a) of the Securities Exchange Act of 1934. There was no solicitation in opposition to the Company&rsquo;s
solicitation. At the meeting, holders of the Company&rsquo;s common stock were asked:</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #000033; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>To elect two (2) Class II directors nominated by the Board of Directors, each to serve until the 2019 Annual Meeting of Stockholders
and until their respective successors are duly elected and qualified;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #000033; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>To approve an amendment to the Company&rsquo;s Restated Articles of Organization to increase the aggregate number of shares
of common stock that the Company is authorized to issue to 60,000,000 shares from 30,000,000 shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #000033; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>To ratify the appointment of PricewaterhouseCoopers LLP as the Company&rsquo;s independent registered public accounting firm
for the 2016 fiscal year; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #000033; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>To consider and approve an advisory vote regarding the compensation of the Company&rsquo;s Named Executive Officers.</TD></TR></TABLE>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">A total of 12,850,565 shares of Common Stock were present in person or
by proxy at the meeting, representing approximately 87.01% of the voting power of the Company entitled to vote at the meeting.
Each share of the Company&rsquo;s common stock was entitled to one vote with respect to matters submitted to a vote of the Company&rsquo;s
stockholders, and the voting results reported below are final.</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0"><B><U>PROPOSAL 1</U></B></P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">Each of the Company&rsquo;s nominees for director as listed in the proxy
statement was elected as shown in the table below: &nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 37%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>Nominee</B></TD>
    <TD STYLE="width: 20%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>Votes &ldquo;For&rdquo;</B></TD>
    <TD STYLE="width: 20%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>Votes Withheld</B></TD>
    <TD STYLE="width: 23%; border-bottom: black 1pt solid">
        <P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>Broker</B></P>
        <P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>Non-Votes</B></P></TD></TR>
<TR>
    <TD STYLE="color: #000033; text-align: center">Mr. Raymond J. Land</TD>
    <TD STYLE="color: #000033; text-align: center">9,047,537</TD>
    <TD STYLE="color: #000033; text-align: center">1,228,264</TD>
    <TD STYLE="color: #000033; text-align: center">2,574,764</TD></TR>
<TR>
    <TD STYLE="color: #000033; text-align: center">Dr. Glenn R. Larsen</TD>
    <TD STYLE="color: #000033; text-align: center">9,639,149</TD>
    <TD STYLE="color: #000033; text-align: center">636,652</TD>
    <TD STYLE="color: #000033; text-align: center">2,574,764</TD></TR>
</TABLE>
<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">As a result of this vote, each of Mr. Land and Dr. Larsen was elected
as a Class II director of the Company to serve until the 2019 Annual Meeting of Stockholders and until their respective successors
are duly elected and qualified.</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0"><B><U>PROPOSAL 2</U></B></P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">Stockholders approved an amendment to Anika Therapeutics, Inc.&rsquo;s
Restated Articles of Organization to increase the aggregate number of shares of common stock that the Company is authorized to
issue to 60,000,000 from 30,000,000 as shown in the table below:</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>For</B></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>Against</B></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>Abstained</B></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid">
        <P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>Broker</B></P>
        <P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>Non-Votes</B></P></TD></TR>
<TR>
    <TD STYLE="color: #000033; text-align: center">10,956,662</TD>
    <TD STYLE="color: #000033; text-align: center">1,787,250</TD>
    <TD STYLE="color: #000033; text-align: center">106,653</TD>
    <TD STYLE="color: #000033; text-align: center">0</TD></TR>
</TABLE>
<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0"><B></B></P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0"><B><U>PROPOSAL 3</U></B></P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">Stockholders ratified the appointment of PricewaterhouseCoopers LLP as
the Company&rsquo;s independent registered public accounting firm for the 2016 fiscal year as shown in the table below:&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>For</B></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>Against</B></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>Abstained</B></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid">
        <P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>Broker</B></P>
        <P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>Non-Votes</B></P></TD></TR>
<TR>
    <TD STYLE="color: #000033; text-align: center">12,779,910</TD>
    <TD STYLE="color: #000033; text-align: center">63,669</TD>
    <TD STYLE="color: #000033; text-align: center">6,986</TD>
    <TD STYLE="color: #000033; text-align: center">0</TD></TR>
</TABLE>
<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0"><B><U>PROPOSAL 4</U></B></P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">Stockholders approved, on an advisory basis, the compensation paid to
the Company&rsquo;s Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion
and Analysis, compensation tables and narrative discussion set forth in the Proxy Statement of the Meeting, as shown in the table
below:</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>For</B></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>Against</B></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid; color: #000033; text-align: center"><B>Abstained</B></TD>
    <TD STYLE="width: 25%; border-bottom: black 1pt solid">
        <P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>Broker</B></P>
        <P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>Non-Votes</B></P></TD></TR>
<TR>
    <TD STYLE="color: #000033; text-align: center">9,885,940</TD>
    <TD STYLE="color: #000033; text-align: center">356,403</TD>
    <TD STYLE="color: #000033; text-align: center">33,458</TD>
    <TD STYLE="color: #000033; text-align: center">2,574,764</TD></TR>
</TABLE>
<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">[Remainder of page left blank intentionally]</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">SIGNATURE</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be filed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td colspan="2" style="vertical-align: middle">Anika Therapeutics, Inc.</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: middle; width: 50%">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; width: 3%">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; width: 27%">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; width: 20%">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: middle">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: middle">Dated: June 6, 2016</td>
    <TD STYLE="vertical-align: middle">By:</td>
    <TD NOWRAP STYLE="vertical-align: middle; padding-left: 15pt; border-bottom: Black 1.1pt solid">/s/ Sylvia Cheung</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: middle; padding-left: 15pt">Sylvia Cheung</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD COLSPAN="2" STYLE="vertical-align: middle; padding-left: 15pt">Chief Financial Officer</td></tr>
</table>


<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
